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ArbovirusesRNA interference (RNAi) controls gene expression in eukaryotic cells and thus, cellular homeostasis. In
addition, in plants, nematodes and arthropods it is a central antiviral effector mechanism. Antiviral RNAi
has been well described as a cell autonomous response, which is triggered by double-stranded RNA
(dsRNA) molecules. This dsRNA is the precursor for the silencing of viral RNA in a sequence-speciﬁc man-
ner. In plants, systemic antiviral immunity has been demonstrated, however much less is known in ani-
mals. Recently, some evidence for a systemic antiviral response in arthropods has come to light. Cell
autonomous RNAi may not be sufﬁcient to reach an efﬁcient antiviral response, and the organism might
rely on the spread and uptake of an RNAi signal of unknown origin. In this review, we offer a perspective
on how RNAi-mediated antiviral immunity could confer systemic protection in insects and we propose
directions for future research to understand the mechanism of RNAi-immune signal sorting, spreading
and ampliﬁcation.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction
Arthropods are of enormous importance to ecology, economy
and health. Some of them, such as sand ﬂies, mosquitoes and ticks,
are vectors for numerous pathogens, including viruses. Among
them, arboviruses (arthropod-borne viruses) are transmitted by in-
sects upon biting vertebrates. Several arboviruses are responsible
for worldwide epidemics and high mortality or morbidity rates
in humans, such as dengue and chikungunya virus. The insect vec-
tors of arboviruses have to control these viral infections to maxi-
mize their survival and minimize the associated ﬁtness cost.
Thus, the insect antiviral response is an important factor for viral
transmission and dissemination.
Since the beginning of the 20th century, the fruit ﬂy Drosophila
melanogaster has been the most widely used insect model. As a re-
sult, Drosophila has become a powerful tool to work in several
ﬁelds, including genetics, development, neuroscience and immu-
nity. This is due to the availability of genetic tools, the short gener-
ation time, the safety of use compared to hematophagous insects,
and more recently, the availability of the complete genome se-
quence. Consequently, much of what is currently known about de-
fense mechanisms in insects results from work with fruit ﬂies. Thisreview therefore focuses on research performed using Drosophila,
although some examples and works in other models, such as in
Caenorhabditis elegans, are addressed.
The defense of higher eukaryotes against pathogens is orga-
nized into different layers. First, there is a non-speciﬁc host de-
fense: a physical barrier, which is the skin in mammals and the
cuticle for insects. The gut epithelia can also be considered as an
anatomical barrier as it protects against infections during feeding
(Buchon et al., 2010; Davis and Engstrom, 2012). Second, there is
innate immunity, which acts coordinately at the cellular and sys-
temic level. The third layer is the adaptive immune response,
which is present only in jawed vertebrates. Some of the most inter-
esting characteristics of this adaptive immunity are the boosting or
ampliﬁcation of the immune response, as well as the immune
memory, which enhances the ability of the organism to respond
to future related infections. However, insects lack an adaptive im-
mune system and thus, the immune defense relies almost entirely
on the innate immune response. For instance, ﬂies are able to trig-
ger various defense pathways depending on the type of infecting
pathogen, and most of these pathways are inter-connected. For
fungal or bacterial infections, the Toll, Imd and Jak/STAT pathways
have been implicated (Agaisse et al., 2003; De Gregorio et al.,
2002). Although these pathways also play a role in viral infections,
their antiviral function seems to be virus-speciﬁc rather than being
a general antiviral response (see for example Dostert et al., 2005;
Zambon et al., 2005; Kemp et al., 2013). A comprehensive descrip-
tion and discussion of these antiviral mechanisms are presented in
this special issue by Sara Cherry and colleagues. Antiviral defense
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RNA interference (RNAi) response (Galiana-Arnoux et al., 2006;
van Rij et al., 2006; Wang et al., 2006; Zambon et al., 2006).
RNAi is a conserved sequence-speciﬁc, gene-silencing mecha-
nism that is induced by double-stranded RNA (dsRNA). Several
RNAi-related pathways (Aravin et al., 2006; Czech et al., 2008;
Girard et al., 2006; Lagos-Quintana et al., 2001; Lau et al.,
2001; Lee and Ambros, 2001; van Rij et al., 2006) have been de-
scribed in many organisms and they have diverse functions,
including the modulation of mRNA translation (Valencia-Sanchez
et al., 2006), establishment of chromosomal architecture (Hall
et al., 2002), regulation of stem cell renewal (Carmell et al.,
2002) and defense against viruses and mobile genetic elements
(Chung et al., 2008). In general terms, RNAi pathways involve
the production of small non-coding RNAs, and their biogenesis
and function is based on two proteins: Dicer (Dcr) and Argona-
ute (Ago). The Dicer and Ago genes are strongly conserved in
wide-ranging species including plants, invertebrates and mam-
mals. Nevertheless, as a result of evolutionary and immune
adaptation processes, there are several paralogues of both pro-
teins. Consequently, a number of functions have been described
for various Ago and Dcr paralogues, including their involvement
in the antiviral responses. As of today, four main RNAi-related
pathways have been described and they can be classiﬁed into
two major groups on the basis of the origin of the small non-
coding RNAs: the ‘‘endogenous’’ group, which involves small
RNAs encoded within the cell and the ‘‘exogenous’’ group, which
involves small RNAs not encoded by the cell.
‘‘Endogenous’’ RNAs:
(i) Micro-RNAs (miRNA) are mostly encoded by intergenic
regions in the nuclear DNA. In Drosophila, their biogenesis
is dependent on Drosha and Pasha in the nucleus, that pro-
cess the primary transcript (pri-miRNA) into a pre-miRNA
(Denli et al., 2004); then the pre-miRNA is exported from
the nucleus to the cytoplasm, where it is processed by Dcr-
1 together with its cofactor Loquacious (a dsRNA binding
protein) to generate the mature miRNA. In association with
Ago1 (Okamura et al., 2004) miRNAs actively regulate cellu-
lar gene expression by several mechanisms ranging from
cleavage of cellular transcripts to translational inhibition.
They may also act at the transcriptional level through, for
example, chromatin reorganization (Pushpavalli et al.,
2012).
(ii) Endogenous small interfering RNAs (endo-siRNA), are
encoded by transposable elements or other genomic regions
that produce transcripts capable of forming dsRNA struc-
tures. They regulate genes and transposable elements. In
Drosophila, this pathway is dependent on Dcr-2, a variant
of Loquacious (loqs-PD) (Zhou et al., 2009) and Ago2
(Kawamura et al., 2008).
(iii) PIWI-interacting RNAs (piRNA) are encoded by clusters of
genes throughout the genome. They are mostly known for
their roles in epigenetic and post-transcriptional gene silenc-
ing of transposons and other genetic elements in the germ
line. Besides, there is evidence implicating piRNAs in the
antiviral response in mosquitoes (Morazzani et al., 2012;
Vodovar et al., 2012). The biogenesis of piRNAs in Drosophila
is dependent on PIWI, Aubergine (Aub) and Ago3 proteins.
This RNAi pathway is Dcr independent (Olivieri et al., 2010).
‘‘Exogenous’’ RNAs:
(i) Small interfering RNAs (siRNA) are produced from virus-
derived dsRNAs or non-cellular RNAs that generate dsRNA
structures. The siRNA pathway works as an antiviral
response in invertebrates and plants, targeting both viraldsRNA replicative intermediates as well as viral genomes.
The biogenesis of siRNA is dependent on Dcr-2, R2D2 and
Ago2.
To understand how insects combat and control viral infections,
we will ﬁrst consider the RNAi pathway at a cellular level during a
viral infection. We will then address how cells may establish intra-
cellular immunity at sites distant from the infected cells, and ﬁnal-
ly discuss how antiviral RNAi generates a systemic response.2. RNAi as an antiviral defense
Viral dsRNA molecules are produced in cells that are infected
with diverse types of virus: (i) viruses with dsRNA genomes, such
as Drosophila X virus (DXV) (Dobos et al., 1979); (ii) viruses with
DNA genomes that contain convergent transcript units, for exam-
ple Invertebrate Iridescent virus (IIV6) (Bronkhorst et al., 2012;
Kemp et al., 2013); and (iii) viruses with single-stranded RNA gen-
omes produce dsRNA as the result of the formation of secondary
structures, such as Sindbis virus (Myles et al., 2008; Fragkoudis
et al., 2009) or vesicular stomatitis virus (Sabin et al., 2013); and/
or replication intermediates as for Drosophila C virus (DCV) or Sem-
liki Forest virus (Siu et al., 2011).
Those long viral dsRNA molecules trigger the antiviral siRNA
pathway (Fire et al., 1998). They are cleaved (or ‘diced’) by a ribo-
nuclease III enzyme, Dcr-2 (Bernstein et al., 2001) in association
with its cofactor R2D2 (Liu et al., 2003), into viral small interfering
RNAs (siRNA) of 21 nt long (Elbashir et al., 2001). These viral siR-
NAs are loaded into a pre-RISC complex, where the siRNA duplex
is unwound and the strand with the less stable 30-terminus, the
passenger strand, is removed. The remaining viral siRNA strand,
the guide strand, is retained in Ago2/holo-RISC, which is the cata-
lytic effector of the RISC complex (Okamura et al., 2004; Rand et al.,
2004). The loaded viral siRNA can bind a viral RNA (genome or
transcript) by sequence complementarity leading to speciﬁc degra-
dation of the targeted RNA mediated by Ago2. The complementar-
ity of the siRNA and its target is thus the basis of the speciﬁcity of
the RNAi machinery.
The siRNA pathway appears to be the main antiviral response in
insects: ﬂies deﬁcient for Dcr-2 or Ago2 are unable to control virus
replication and as a consequence are hypersensitive to infection
(Galiana-Arnoux et al., 2006; van Rij et al., 2006; Wang et al.,
2006; Zambon et al., 2006). Recently, some reports suggest the
involvement of other RNAi pathways in the control of viral infec-
tions. Indeed, piRNAs from viral origin have been detected by
deep-sequencing during infections of mosquitoes with arboviruses,
including dengue (Hess et al., 2011), Sindbis (Vodovar et al., 2012),
chikungunya (Morazzani et al., 2012) and LaCrosse virus (Brackney
et al., 2010). Hess and colleagues (Hess et al., 2011) described an
in vivo assay using mosquitoes and dengue virus, and detected a
peak in the accumulation of piRNAs at 2 days post infection. The
amounts of these piRNAs then decreased during the infection,
whereas siRNA production increased. This suggests that the
RNAi-Dcr-2-dependent pathway is active during viral infection,
but that it is preceded by the piRNA response. These observations
lead to the notion that the piRNA pathway may initiate the antivi-
ral process during a viral infection in mosquitoes. It is important to
note that, in Drosophila, siRNAs accumulate during viral infection
independently from piRNA production. It has been suggested that
piRNAs may serve as epigenetic and genomic ‘‘security guards’’.
Recently Schnettler and colleagues (Schnettler et al., 2013) pro-
vided the ﬁrst functional demonstration that viral piRNAs do in-
deed contribute to antiviral defenses in mosquito cells infected
with Semliki Forest virus.
Interestingly, viruses like Epstein-Barr virus encode miRNAs,
which can interfere with the mammalian immune response. These
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liferation, apoptosis (Riley et al., 2012) and components of signal
transduction pathway among others (Marquitz and Raab-Traub,
2012). Klase and colleagues proposed that HIV-1 TAR element is
processed by Dicer to produce a viral miRNA that is detectable in
infected cells, which contribute to viral latency (Klase et al.,
2007). Arthropod viruses have been predicted to encode miRNA,
but there has been scarce biological or experimental demonstra-
tion that they are indeed produced. In 2012, Hussain and
colleagues (Hussain et al., 2012) showed that West Nile virus
encodes a miRNA in its 3’ untranslated region. This miRNA is only
detected in mosquito cells but not in mammalian cells infected
with this virus. Regulation by this miRNA, named KUN-miR-1,
increases the cellular GATA4 mRNA, which leads to a higher viral
replication.
Several lines of evidence imply the existence of a systemic com-
ponent to the siRNA pathway in arthropods: (i) the in vivo uptake
of exogenous dsRNA; (ii) an increased sensitivity of dsRNA uptake
mutants to viral infection; and (iii) the trans-silencing effects on
endogenous genes following Sindbis virus infection in Drosophila.
Early in 2002 it was shown that dsRNA injection into the haemo-
coel of adult Tribolium castaneum (ﬂoor beetle) resulted in knock-
down of zygotic genes, which was also manifested in offspring
embryos, implying transfer across cell boundaries (Bucher et al.,
2002). In 2005, Robalino and colleagues showed that the injection
of viral sequence-speciﬁc dsRNA confers potent antiviral immunity
in vivo in the shrimp Litopenaeus vannamei (Robalino et al., 2005).
Accordingly, endogenous shrimp genes could be silenced in a sys-
temic fashion by the administration of cognate long dsRNA. A sys-
temic component to antiviral RNAi was shown in mosquito cells
infected with Semliki Forest virus (Attarzadeh-Yazdi et al., 2009).
Even if the exact mechanism is not known, the authors showed
cell-to-cell spread of viral-derived siRNA, and possible long dsRNA,
with concomitant inhibition of replication of the incoming viruses
in cells neighboring infected cells. Also, we were able to show that
in Drosophila, intra-thoracic injection of viral sequence-speciﬁc
long dsRNA into uninfected ﬂies conferred immunity against sub-
sequent infection with the corresponding virus. Furthermore,
infection with Sindbis virus expressing the green ﬂuorescent pro-
tein (GFP) suppressed expression of host-encoded GFP at a distal
site of infection (Saleh et al., 2009).
Therefore, systemic RNA silencing pathways seem to exist in at
least some arthropods. The link between systemic RNAi and antivi-
ral defense awaits further mechanistic conﬁrmation. Through the
rest of this review we offer a perspective on how the RNAi-medi-
ated antiviral immunity could confer systemic protection and we
propose directions for further study to understand the mechanism
of RNAi-immune signal sorting, spreading and ampliﬁcation.3. Setting up antiviral immunity at systemic level
The control of viral infections in mammals requires signaling
molecules to elicit an effective response and to establish systemic
immunity at the organismal level. These signals must be ampliﬁed
and disseminated throughout the organism to avoid pathogen
propagation and establishment of the infection. In Drosophila,
although it has been postulated that there is a systemic antiviral
response, neither the signal, nor the ampliﬁcation mechanism,
nor the mechanism of its dissemination, has been described. Nev-
ertheless, relevant data are starting to emerge.3.1. Uptake and sorting of the immune signal
Drosophila cells can take up viral dsRNA that triggers a speciﬁc
RNA silencing response (Caplen et al., 2000). Presumably, followingdsRNA uptake, an immune signal is sent by infected cells to pre-
vent viral infection in distant non-infected cells (Saleh et al.,
2009; Attarzadeh-Yazdi et al., 2009). Non-infected cells have to
be able to ‘‘catch’’ or to ‘‘sense’’ this signal and to internalize it in
order to be primed. Here, we will address the possible triggers,
the signals and their sorting.
For the uptake of viral dsRNA or other viral infection signals by
non-infected cells, the ﬁrst barrier to be crossed is the plasma
membrane, a bilayer of phospholipids with associated proteins.
The plasma membrane is selectively permeable to small and un-
charged molecules; however, most molecules are unable to freely
diffuse through it. Various membrane proteins act as receptors
and/or transporters allowing adequate and selective entry of mol-
ecules into the cell. It has been shown that the endocytic clathrin-
dependent mechanism is involved in the uptake of dsRNA and this
triggers an antiviral RNAi pathway in Drosophila (Saleh et al., 2006;
Ulvila et al., 2006). Indeed, the speciﬁc uptake of dsRNA by cells is
abolished by treatment with Baﬁlomycin-A1, an inhibitor of V-H-
ATPase (a component of the endosome-lysosomal acidiﬁcation
process). Viral dsRNA and naked siRNA are large and charged mol-
ecules, and therefore there must be appropriate receptors if they
have to enter into the cells. In C. elegans there are two receptors
for dsRNA: SID-1 allows passive inter-cellular transport (Feinberg
and Hunter, 2003; van Roessel and Brand, 2004; Winston et al.,
2002), whereas SID-2 allows active transport of environmental
dsRNA from the intestinal lumen into cells (McEwan et al., 2012).
These receptors participate in the internalization of dsRNA, which
can then lead to the spread of the RNAi. Other SID proteins that
participate in dsRNA transport have been described, like SID-5,
which promotes the transport of the silencing signal between cells
in C. elegans (Hinas et al., 2012), or SID-3, which is needed for an
efﬁcient import of dsRNA into cells (Jose et al., 2012). Interestingly,
the extent to which RNAi spreads is coupled to the amount of
dsRNA produced within cells or imported from the environment
(Jose et al., 2011). However, although dsRNA is able to enter cells
in ﬂies, it is not clear how. No receptors with a dsRNA-binding do-
main have been found in Drosophila. It appears that two Scavenger
receptors, called SR-CI and Eater, are associated with dsRNA uptake
(Ulvila et al., 2006) but further studies addressing the role of these
receptors are needed.
It is also possible that dsRNA is not the signal that triggers sys-
temic immunity, in which case, there must be another molecule.
However, studies in cell culture using Drosophila S2 cells found
that free siRNAs are not taken up by the cells, and/or do not result
in silencing of a reporter gene when freely added to the extracellu-
lar media (Saleh et al., 2006; Ulvila et al., 2006). These results are
consistent with the notion that the signal of systemic immunity
may be a long dsRNA, a (RNP), or another RNA complex.
Assuming an RNA nature of the signal, insights into the trans-
port of other RNA species, for example miRNA or mRNA, may be
informative about the uptake of the immune signal in ﬂies. In mur-
ine and human cells, naked mRNA has been shown to associate
with early endosomes (Rab5-positive vesicles) after endocytosis
probably mediated by a Scavenger receptor. However, this entry
route is not exclusive for mRNA and other negatively charged mol-
ecules, including all small RNAs and dsRNA, could potentially use
it. After internalization, the mRNA was found to trafﬁc into lyso-
somes where it accumulates and is then degraded by ribonucle-
ases; however, an important proportion of the RNA escapes to
the cytoplasm where it can be expressed (Lorenz et al., 2011)
(Fig. 1B and C).
Many RNAs are addressed to speciﬁc subcellular compartments
by (i) a signal that they carry in their sequence or by structural mo-
tifs (cis-acting elements or localizer signals) and/or by (ii) associ-
ated proteins (trans-acting factors) (Bashirullah et al., 1998). The
cis-acting elements provide binding sites for the trans-acting
Fig. 1. Hypothetical model for internalization, sorting and transmission of the
RNAi-immune signal during virus infection. At the site of infection (A), the presence
of dsRNA activates the antiviral response at the cellular level and sets up the
immune signal for a systemic response. This signal could spread through the
organism by (B) exosomes containing siRNAs or an RNP or long dsRNA from viral
replication. At distant sites of infection (C) the immune signal is potentially
endocytosed, followed by release from lysosomes. Long viral dsRNA is diced and
siRNAs loaded into RISC or in free RNP. Alternatively, some naked dsRNA can be
diced and siRNAs direct to GW-bodies or P-bodies where active silencing and viral
mRNA decay control future infections (D).
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dozen of nucleotides long, are unlikely to encode such localizer
sequences.
Therefore, the effectiveness of the silencing process not only de-
pends on internalization of the signal; the signal must also be
delivered to the appropriate site to allow the production of siR-
NA-based sequence-speciﬁc protection. The internalization of
transmembrane proteins and cargo can provide a clue on this pro-
cess. Endocytic vesicles with transmembrane proteins and ligands
are internalized and they deliver their cargo to the early endo-
somes where the cargo is sorted to (i) be sent back to cell surface
through recycling endosomes or (ii) remain in the early endosome,
which develop into multi-vesicular bodies (MVBs) by invagination
of their membranes (Felder et al., 1990; Hurley and Emr, 2006;
Matsuo et al., 2004). If the acidiﬁcation continues, the number of
internal vesicles will increase; late endosomes (multi-vesicular
endosomes) fuse with lysosomes and their contents are then de-
stroyed. MVBs are either sorted for degradation into lysosomes,
although a proportion of internalized mRNAs can escape to be ex-
pressed in the cytoplasm, or secreted as exosomes into extracellu-
lar ﬂuids. Interestingly, MVBs have been found to be closely
involved with the miRNA and the siRNA pathways (Lee et al.,
2009). In mammals, for example, Epstein-Barr virus encodes its
own miRNAs that are released within exosomes with immuno-
modulatory properties (Pegtel et al., 2010). Several pathways for
targeting proteins into MVBs have been described in ﬂies. Mono-
ubiquitinated proteins are sorted from the endosomes to the outer
membranes of MVBs bound to the ESCRT complex (Endosomal
Sorting Complex Required for Transport) (Katzmann et al., 2001).
It is therefore possible that dsRNA and/or siRNA could be ad-
dressed towards MVB following their inclusion in RNP subject to
ubiquitination (Fig. 1C). Although the role of MVBs in the trafﬁc
and sorting of the immune signal has thus far not been addressed,
their key roles in vesicular trafﬁcking make them good candidates
to start exploring the mechanism of dsRNA transport.
Another interesting candidate for the accumulation and pro-
cessing of dsRNA and/or siRNA, as part of the intracellular immu-
nity system, are GW-bodies (Fig. 1C). In mammals, these
cytoplasmic foci are physically associated with MVBs, which are
involved in the post-transcriptional regulation of eukaryotic gene
expression (Anderson and Kedersha, 2009). They are enriched in
mRNAs, small RNAs (miRNA and siRNA) and RNA-binding proteins
associated with the RNAi pathway, such as Ago2 (which has also an
mRNA degradation function in mammals) and GW182 (Jakymiw
et al., 2005; Liu et al., 2005; Sen and Blau, 2005) of which there
is an homologue in Drosophila (Rehwinkel et al., 2005). In mamma-
lian cells, GW-bodies are essential for the miRNA pathway (active
miRISC is recruited into GW-bodies (Gibbings et al., 2009; Lee
et al., 2009)), and the disruption of this structure impairs the
silencing of endogenous genes. Transfected siRNA are also found
in these GW-bodies (Jakymiw et al., 2005).
Foci very similar to GW-bodies are also found in Drosophila, C.
elegans and mammalian cells and are called P-bodies (Fig. 1C)
(Sheth and Parker, 2003; Jain and Parker, 2013). One of the main
differences between GW-bodies and P-bodies is that P-bodies pos-
sess decapping proteins involved in mRNA decay. One of the func-
tions associated with AIN-1 protein (the GW182 homologue in C.
elegans (Ding et al., 2005)) is the translocation of miRNAs to P-
bodies. The recruitment of miRNA into P-bodies appears to allow
the decay of target mRNA, and there may be a similar mechanism
for viral siRNA and viral RNA in Drosophila. There are two lines of
evidence supporting this possibility: (i) various components of
the RISC complex have been detected in P-bodies (i.e, presence of
dFMR1 (Caudy et al., 2002; Ishizuka et al., 2002)) and (ii) active
silencing pathways are necessary for P-bodies to form in Drosophila
although P-bodies are not required for silencing (Eulalio et al.,
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cruited; these enzymes are involved in mRNA decay, which may al-
low the degradation of viral mRNA (deadenylation and digestion
by exonucleases) (Fig. 1D). This mechanism is a possible second
route for promoting intracellular immunity.
3.2. Spread of the immune signal
During a viral infection, the immune signal, whatever its nature,
needs to be shared throughout the organism if a systemic antiviral
response is to develop. As such, it would be possible to ﬁnd dsRNA
or siRNA at locations distant from the infection site. One plausible
explanation for systemic spread is the lysis of the infected cells.
However, this would not explain the protection observed in organ-
isms infected with viruses that do not display a cytopathic effect.
Therefore, there must be an active process to share and alert the
neighboring and distant non-infected cells to allow a speciﬁc anti-
viral protection mediated by RNAi.
Exosomes are tiny vesicles generated from MVBs when they
fuse to the plasma membrane (Fig. 1A and B), and they can carry
mRNA and miRNA (Valadi et al., 2007; Huan et al., 2013) and both
endogenous and exogenous proteins, including toxins (Zhang et al.,
2009). Therefore, it has been suggested that exosomes may be
responsible for exchange of material between cells. Exosomes are
found in many different ﬂuids, including blood, breast milk, amni-
otic ﬂuid and malignant ascites (Denzer et al., 2000; Lasser et al.,
2011; Runz et al., 2007). Then, it is tempting to speculate that in
Drosophila they may travel through the hemolymph carrying and
propagating the immune signal. There is increasing evidence that
exosomes in mammals can be taken up by other cells following
recognition by receptors on the plasma membrane (MiyanishiA B
Fig. 2. Proposed mechanisms for ampliﬁcation of the antiviral RNAi response. (A and B) D
transcriptional units or replication intermediates forming dsRNA are diced into primary s
Additionally, the siRNA now in duplex with the viral RNA, can be used as template for a
new dsRNA is generated and diced, producing secondary siRNAs, also loaded in antivira
unwound. The single-stranded primary siRNA anneals with viral RNA (B). By ligation, new
amplifying the initial immune signal. (C) Cellular reverse transcriptase associated to r
derived-DNA form is transcribed and produces dsRNA, which will in turn be diced, gener
canonical RNAi antiviral response.et al., 2007; Nolte-‘t Hoen et al., 2009) and that they are carriers
for many and diverse cargos depending on their cell origin. The up-
take of free exosomes is currently the subject of lively debate. It
has been suggested that after release from a cell, exosomes are
endocytosed and targeted, along the cytoskeleton, to lysosomes
(Tian et al., 2012). Other authors suggest that exosomes can be im-
ported into cells by phagocytosis (Feng et al., 2010) or by fusion
(Parolini et al., 2009). It is possible that exosomes fuse with the
endocytic compartment after endocytosis and during acidiﬁcation,
they release their content in lysosomes. However, a large part of
their contents escape and these escaped contents can include pro-
teins, such as Ago2 and GW182 (Gibbings et al., 2009), and mole-
cules such as siRNA and dsRNA. Silencing by small RNA is linked
to endosomal trafﬁcking (Lee et al., 2009) and it has been demon-
strated that exosomes are involved in the immune system (Admyre
et al., 2007). In mammals, for example, exosomes act as immuno-
logical mediators associated with tumor growth by exosome-med-
iated miRNA transfer (Kogure et al., 2011; Liu et al., 2006). In ﬂies,
exosome-like vesicles, called argosomes, are responsible for a
graded distribution of morphogens, such as Wingless (Greco
et al., 2001). This newly described route for intracellular communi-
cation has become a topic under intense study and we expect that
it will soon become clear whether exosomes have an antiviral role
during viral infection in insects.
Exosomes are not the only way that small RNAs use to circulate.
Arroyo and colleagues (Arroyo et al., 2011) showed that in mam-
mals, miRNA contained in exosomes constitutes only a minority
of the circulating miRNA and the bulk of miRNA is found in the
plasma as ribonucleoprotein complexes associated with Ago pro-
tein. Embedding small RNA in an RNP has several advantages as
a mechanism of dissemination: it may improve RNA stability andC
uring virus infection, genomic dsRNA, secondary structures, convergent overlapping
iRNAs. The siRNA can be loaded in RISC complex to direct the cleavage of viral RNA.
cellular RNA-dependent RNA-polymerase (RdRP). cRNA: complementary RNA (A). A
l RISC. Alternatively, by an unknown mechanism, the primary siRNA duplex can be
dsRNA is produced, diced into secondary siRNAs that are loaded into RISC, thereby
etrotransposons produce a viral derived-DNA form from the viral RNA. This viral
ating siRNAs. These DNA-derived siRNAs are loaded in antiviral RISC amplifying the
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in a ‘‘ready-state’’ to regulate gene expression in recipient cells.
A graphic representation of the concepts developed in Sections
3.1 and 3.2 regarding internalization, sorting and transmission of
the RNAi-immune signal is presented in Fig. 1.3.3. Ampliﬁcation of the immune signal
In a number of organisms, including plants and C. elegans, gene
inactivation by silencing persists through cell division, can be
spread to other tissues, and is heritable (Wianny and Zernicka-
Goetz, 2000; Vaistij et al., 2002; Chuang and Meyerowitz, 2000).
Therefore, even with very few inducer molecules of dsRNA, there
must be a mechanism for the self-sustaining nature of RNAi. When
C. elegans is fed or transfected with dsRNA, the dsRNA is diced into
siRNA duplexes that are called primary siRNA. Primary siRNA trig-
gers the speciﬁc silencing of the target RNA. A thorough study of
the population of small RNAs recovered after dicing of the dsRNA
revealed the presence of primary siRNAs as well as siRNAs with se-
quence characteristics (i.e. 50-triphosphate) that excludes them
from being digestion products of the dsRNA. These siRNAs are
named secondary siRNA (Sijen et al., 2001). Several mechanisms
for the biogenesis of secondary siRNA have been proposed
(Fig. 2): (i) single-stranded (ss) siRNA may anneal with its target
RNA, and could serve as primer for producing a complementary
strand of the template RNA (cRNA); the resulting cRNA/RNA du-
plex would then constitute a dsRNA that could be degraded by
Dcr, and again, loaded into RISC complexes. This mechanism allows
the ampliﬁcation of the initial signal, producing secondary siRNAs,
which were not part of the initial dsRNA. This mechanism relies on
an RNA-dependent RNA-polymerase (RdRP) (Tijsterman et al.,
2002) (Fig. 2A). (ii) ss siRNAs may anneal to the RNA target by com-
plementarity covering its entire length. A kinase may ligate siRNAs
to form a new cRNA and consequently a cRNA/RNA duplex (a
dsRNA molecule) (Nishikura, 2001). The dicing of this new dsRNA
would produce secondary siRNAs, allowing the ampliﬁcation of
the signal, and the silencing of the target RNA (Fig. 2B).
Despite years of intense research, there have been no conclusive
evidence for secondary siRNAs or RdRP activity in Drosophila. Inter-
estingly, we recently described that during persistent viral infec-
tions non-retroviral RNA viruses can exploit cellular reverse
transcriptases to produce a DNA form of viral origin early during
the infection (Goic et al., 2013). This DNA of viral origin produces
transcripts that can generate dsRNA, which in turn boosts siRNA-
mediated immunity. The notion that DNA of viral origin can have
immune functions had already been suggested for Israeli acute
paralysis virus in Apis mellifera (honeybees): insects carrying a
DNA insertion with substantial sequence identity with the RNA
virus were resistant to the virus (Maori et al., 2007). It is then
tempting to speculate that in the absence of a canonical RdRP that
accounts for the production of secondary small RNAs in insects, the
mechanism of transforming viral RNA > DNA > RNA > small RNA,
could be amplifying the antiviral immune response throughout
the insect’s life (Fig. 2C). By the mechanism proposed, the RNAi-
immune response is triggered by viral dsRNA replication interme-
diates, and ampliﬁed and boosted through newly generated viral
DNA-derived dsRNA molecules. Future studies should shed light
on the role of endogenized viral sequences in the ampliﬁcation of
the immune signal.4. Closing remarks
There have been great advances over the last decade in our
knowledge about immunity in non-mammalian models including
plants and arthropods. Among them, the discovery of RNAi as animmune response revolutionized our way of conceiving host–virus
interactions. This helped to improve the control of agricultural
pests (Huang et al., 2006) and also contributed to our understand-
ing of mammalian immunology.
Nowadays, the antiviral RNAi in Drosophila is well characterized
as a cellular response based on the nuclease activities of Dcr-2 and
Ago2. This response has also been found in almost every insect
model tested. However, less is known about the role of the RNAi
response as an immune system. The inducer signal for a systemic
response remains still unknown. Nevertheless, evidence points to
a signal of RNA nature (dsRNA, small RNA or RNP). The way in
which these molecules are released from the infected site to be
sensed and internalized by non-infected cells are also open ques-
tions. New ﬁndings and applications from the cell biology ﬁeld will
allow in-depth understanding of the role of endocytosis and traf-
ﬁcking vesicles in the RNAi systemic immunity in invertebrates.Acknowledgements
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